SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-17-023341
Filing Date
2017-01-30
Accepted
2017-01-30 15:29:02
Documents
4
Group Members
BIOMARK CAPITAL FUND IV GP LLCDAVID S. WETHERELL

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d281871dsc13da.htm SC 13D/A 74249
2 EX-99.A d281871dex99a.htm EX-99.A 5027
3 EX-99.B d281871dex99b.htm EX-99.B 9420
4 EX-99.2 d281871dex992.htm EX-99.2 70790
  Complete submission text file 0001193125-17-023341.txt   161205
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Subject) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82025 | Film No.: 17557018
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 537 STEAMBOAT RD., SUITE 200 GREENWICH CT 06830
Business Address 537 STEAMBOAT RD., SUITE 200 GREENWICH CT 06830 203-769-2345
BIOMARK CAPITAL FUND IV LP (Filed by) CIK: 0001614166 (see all company filings)

IRS No.: 452626874 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A